default author photo

Yi-Li Ma

Guangxi Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Comparison of Post-Resection Survival between Patients with Hepatocellular Carcinoma Beyond the 'Up-To-7' Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: Prospective Data Analysis Based on Target Trial Emulation

Number of pages: 34 Posted: 25 Oct 2025
Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Cancer Hospital, Liuzhou People's Hospital, Hospital of Nanning - The Second People's Hospital of Nanning, Guigang People's Hospital, People’s Hospital of Guangxi Zhuang Autonomous Region, People's Hospital of Wuzhou, Guangxi Medical University, Guangxi Medical University, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi University of Chinese Medicine (GXTCM), Nanning First People’s Hospital, Yulin First People's Hospital, Lingshan County People’s Hospital, Guangxi Medical University, First People’s Hospital of Qinzhou, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University, Guangxi Medical University, Guangxi Medical University - Department of Hepatobiliary Surgery, Guangxi Medical University - Department of Hepatobiliary Surgery and Guangxi Medical University - Department of Hepatobiliary Surgery
Downloads 46 (1,133,231)

Abstract:

Loading...

Adjuvant, curative resection, hepatocellular carcinoma, PD-1 inhibitor, up-to-7 criterion